Consigue una respuesta de este empleador
Tu currículum y tu carta de presentación, adaptados exactamente a lo que buscan contratar.
Pharming Group is seeking a Regional Medical Science Liaison to drive Named Patient Programs across Europe in a remote-capable role. The MSL will engage with KOLs and physicians, support NPP activities, and collaborate with Medical Affairs and Market Access, with approximately 60% travel.
The ideal candidate will have 7+ years in Medical Affairs/MSL, a PhD/MD/PharmD or equivalent, fluent English, and experience across European markets.
Select how often (in days) to receive an alert: Create Alert
Location:
Remote role based in The Netherlands, France, Italy, or Germany, with the ability to travel extensively across Europe (approximately 60% travel).
Purpose of the rol:
Purpose of the rol:
The Regional Medical Science Liaison (MSL) is responsible for the Named patient program execution cross-functionnally in Europe excluding Germany, France, Italy and UK. The role consists in building strong scientific relationships with healthcare professionals, Key Opinion Leaders (KOLs) and rare disease experts across European markets, supporting Pharming's ambition to expand access to innovative treatments for patients living with rare diseases.
The role focuses on supporting the medical and scientific aspects of Named Patient Programs (NPP), engaging with treatment centres and physicians caring for PID, APDS diagnosed patients and patients receiving Leniolisib, and facilitating appropriate collaboration to support sustainable patient access pathways. Working with partners, access team, liaising from patients to pharmacy to ensure treatment is delivered.
Working closely with International Medical Affairs as well as the Partner and NPP team commercial and Market Access, the Regional MSL contributes to disease awareness, scientific exchange and stakeholder engagement across Europe, while maintaining key experts relationships in Spain.
This is an entrepreneurial, field-based role requiring strong scientific expertise, agility, strategic priority setting, collaboration and a proactive "can-do" mindset to build an innovative and efficient regional medical engagement model.
Areas of responsibility:
Scientific Engagement & Expert Relationships
Named Patient Program Medical Support
Medical Education
Cross-Functional Collaboration & Execution
Your profile:
Education
Experience
We are looking for someone who:
Who we are
We’re built on a simple belief: people living with rare diseases deserve more.
Pharming is a global biotechnology company taking on some of the toughest rare disease challenges. We develop and commercialize innovative therapies for rare and ultra-rare immunological and genetic diseases with significant unmet need, where our scientific and commercial expertise, long-term commitment, and real partnership can help advance care.
We put patients at the heart of our work. Their insights, along with those of caregivers, clinicians, scientists, and partners, shape our strategy, guide our decisions, and help turn science into meaningful progress. We keep it simple, act with urgency, and get it done — expanding access to approved therapies, advancing high-value pipeline programs, and building a leading global rare disease company.
Our vision is simple: a world where people living with rare diseases don’t wait for progress or care. Together with the communities who inspire us, we’re opening new possibilities — proving that breakthroughs aren’t just discovered. They’re created together.
Ready to make a difference? Join us.
What it’s like to work here
At Pharming, every role helps move rare disease therapies closer to the people who need them. We make it happen together, across teams, disciplines, and borders, because breakthroughs don’t happen in silos. Rare diseases are complex, and meaningful progress takes people who ask better questions, challenge each other, and turn insight into action. Here, you won’t work on the sidelines. Pharming is a place for builders, problem-solvers, and bold thinkers who move with urgency, take ownership, and stay focused on what matters most: improving the lives of people living with rare diseases. Advancing rare disease care isn’t the work of one team or one leader. It’s all of us, building what’s next together.